| detection of mechanical stimulus involved in sensory perception of sound | GO:0050910 | 16 | 1.000 | |
| auditory receptor cell morphogenesis | GO:0002093 | 15 | 1.000 | |
| inner ear receptor cell development | GO:0060119 | 39 | 1.000 | |
| retina homeostasis | GO:0001895 | 23 | 1.000 | Human |
| inner ear receptor stereocilium organization | GO:0060122 | 23 | 1.000 | |
| auditory receptor cell stereocilium organization | GO:0060088 | 12 | 1.000 | |
| vestibular receptor cell development | GO:0060118 | 2 | 1.000 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 1.000 | |
| hair cell differentiation | GO:0035315 | 40 | 1.000 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 1.000 | |
| sensory perception of sound | GO:0007605 | 97 | 1.000 | |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 23 | 1.000 | |
| equilibrioception | GO:0050957 | 3 | 0.999 | Human |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.999 | |
| ear development | GO:0043583 | 200 | 0.999 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.999 | |
| epidermis development | GO:0008544 | 187 | 0.998 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.998 | Human |
| post embryonic organ morphogenesis | GO:0048563 | 8 | 0.997 | |
| cardiac muscle tissue growth involved in heart morphogenesis | GO:0003245 | 1 | 0.996 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.993 | Human |
| auditory receptor cell development | GO:0060117 | 20 | 0.992 | |
| positive regulation of dipeptide transmembrane transport | GO:2001150 | 2 | 0.988 | |
| mannitol transport | GO:0015797 | 1 | 0.984 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.981 | |
| sulfate transmembrane transport | GO:1902358 | 3 | 0.978 | |
| detection of mechanical stimulus | GO:0050982 | 27 | 0.975 | |
| ear morphogenesis | GO:0042471 | 118 | 0.975 | |
| blood coagulation | GO:0007596 | 76 | 0.974 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.972 | |
| intracellular ph elevation | GO:0051454 | 3 | 0.967 | |
| parallel actin filament bundle assembly | GO:0030046 | 2 | 0.962 | |
| actin filament organization | GO:0007015 | 113 | 0.961 | |
| skin development | GO:0043588 | 220 | 0.961 | |
| cellular response to fructose stimulus | GO:0071332 | 2 | 0.953 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.949 | |
| sulfate transport | GO:0008272 | 3 | 0.924 | |
| epithelial cell development | GO:0002064 | 159 | 0.922 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.915 | |
| detection of mechanical stimulus involved in equilibrioception | GO:0050973 | 2 | 0.896 | |
| locomotory behavior | GO:0007626 | 195 | 0.885 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.880 | |
| filtration diaphragm assembly | GO:0036058 | 1 | 0.878 | |
| sensory perception | GO:0007600 | 245 | 0.872 | |
| coagulation | GO:0050817 | 78 | 0.867 | |
| establishment of body hair or bristle planar orientation | GO:0048104 | 2 | 0.860 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.851 | Human |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.844 | Human |
| ectodermal cell fate commitment | GO:0001712 | 1 | 0.844 | |
| heterophilic cell cell adhesion via plasma membrane cell adhesion molecules | GO:0007157 | 20 | 0.839 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 44 | 0.816 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.815 | |
| sphingosine 1 phosphate signaling pathway | GO:0003376 | 3 | 0.790 | |
| phagolysosome assembly | GO:0001845 | 3 | 0.769 | |
| phagosome maturation | GO:0090382 | 4 | 0.739 | |
| neuromuscular process | GO:0050905 | 99 | 0.719 | Human |
| post embryonic organ development | GO:0048569 | 17 | 0.716 | |
| detection of external stimulus | GO:0009581 | 61 | 0.714 | |
| positive regulation of dipeptide transport | GO:2000880 | 2 | 0.693 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.693 | Human |
| lateral line system development | GO:0048925 | 1 | 0.689 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.687 | |
| detection of stimulus | GO:0051606 | 84 | 0.687 | |
| oligopeptide transmembrane transport | GO:0035672 | 4 | 0.669 | |
| visual perception | GO:0007601 | 52 | 0.660 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.650 | |
| pilomotor reflex | GO:0097195 | 3 | 0.648 | |
| nonmotile primary cilium assembly | GO:0035058 | 8 | 0.645 | |
| tissue homeostasis | GO:0001894 | 115 | 0.642 | Human |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.615 | |
| cochlea development | GO:0090102 | 35 | 0.615 | |
| multicellular organism growth | GO:0035264 | 161 | 0.593 | |
| peptide cross linking | GO:0018149 | 10 | 0.586 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.586 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.571 | |
| adult walking behavior | GO:0007628 | 41 | 0.566 | |
| establishment or maintenance of apical basal cell polarity | GO:0035088 | 21 | 0.547 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.547 | |
| vestibular receptor cell morphogenesis | GO:0060116 | 1 | 0.540 | |
| righting reflex | GO:0060013 | 9 | 0.540 | |
| polyol transport | GO:0015791 | 4 | 0.517 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.515 | |
| regulation of oligopeptide transport | GO:0090088 | 2 | 0.514 | |
| reflex | GO:0060004 | 22 | 0.500 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.499 | |
| transepithelial chloride transport | GO:0030321 | 4 | 0.492 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.489 | |
| actin filament based movement | GO:0030048 | 23 | 0.477 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.469 | |
| adult behavior | GO:0030534 | 135 | 0.464 | |
| sterol homeostasis | GO:0055092 | 45 | 0.461 | |
| endothelial cell development | GO:0001885 | 20 | 0.461 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.457 | |
| epithelial cell differentiation involved in kidney development | GO:0035850 | 23 | 0.453 | |
| potassium ion transport | GO:0006813 | 52 | 0.447 | |
| cell adhesion | GO:0007155 | 329 | 0.437 | |
| organelle localization | GO:0051640 | 179 | 0.437 | |
| sensory system development | GO:0048880 | 3 | 0.432 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.430 | |
| vestibular reflex | GO:0060005 | 4 | 0.409 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.408 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.408 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.398 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.391 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.379 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.367 | |
| positive regulation of oligopeptide transport | GO:2000878 | 2 | 0.365 | |
| hemostasis | GO:0007599 | 78 | 0.365 | |
| neurohypophysis development | GO:0021985 | 2 | 0.364 | |
| sulfur compound transport | GO:0072348 | 9 | 0.359 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.353 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.346 | |
| ph elevation | GO:0045852 | 3 | 0.339 | |
| interleukin 5 secretion | GO:0072603 | 2 | 0.335 | |
| endocytosis | GO:0006897 | 168 | 0.333 | |
| sperm individualization | GO:0007291 | 1 | 0.329 | |
| drug transport | GO:0015893 | 7 | 0.325 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.320 | |
| lamellipodium organization | GO:0097581 | 29 | 0.317 | |
| sperm capacitation | GO:0048240 | 17 | 0.311 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.310 | |
| regulation of cardiac muscle adaptation | GO:0010612 | 2 | 0.307 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.287 | |
| regulation of systemic arterial blood pressure by atrial natriuretic peptide | GO:0003050 | 2 | 0.285 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.280 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.278 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.270 | |
| ectoderm formation | GO:0001705 | 3 | 0.265 | |
| myosin filament organization | GO:0031033 | 3 | 0.265 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.265 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.264 | |
| regulation of cardiac muscle hypertrophy in response to stress | GO:1903242 | 2 | 0.263 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.262 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.260 | |
| membrane hyperpolarization | GO:0060081 | 21 | 0.255 | |
| cell maturation | GO:0048469 | 127 | 0.248 | |
| inner cell mass cell fate commitment | GO:0001827 | 2 | 0.246 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.245 | |
| bleb assembly | GO:0032060 | 5 | 0.244 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.242 | |
| muscle hypertrophy in response to stress | GO:0003299 | 10 | 0.239 | |
| glutamate secretion | GO:0014047 | 8 | 0.239 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.238 | |
| establishment of mitochondrion localization | GO:0051654 | 4 | 0.236 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.235 | |
| lysosome organization | GO:0007040 | 21 | 0.235 | |
| regulation of hormone metabolic process | GO:0032350 | 15 | 0.235 | |
| inorganic anion transmembrane transport | GO:0098661 | 29 | 0.234 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.222 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.219 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.218 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.214 | |
| transdifferentiation | GO:0060290 | 1 | 0.212 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.207 | |
| positive regulation of thyroid hormone generation | GO:2000611 | 2 | 0.203 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.201 | |
| organelle assembly | GO:0070925 | 177 | 0.197 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.190 | |
| cation homeostasis | GO:0055080 | 212 | 0.190 | |
| regulation of wound healing | GO:0061041 | 40 | 0.189 | |
| calcium ion dependent exocytosis | GO:0017156 | 35 | 0.189 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.189 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.188 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.188 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.188 | |
| positive regulation of macrophage chemotaxis | GO:0010759 | 5 | 0.185 | |
| neuron projection guidance | GO:0097485 | 141 | 0.183 | |
| calcium dependent cell cell adhesion via plasma membrane cell adhesion molecules | GO:0016339 | 9 | 0.179 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.175 | |
| bicarbonate transport | GO:0015701 | 7 | 0.174 | |
| proprioception involved in equilibrioception | GO:0051355 | 1 | 0.170 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.170 | |
| regulation of secretion | GO:0051046 | 274 | 0.168 | |
| neural retina development | GO:0003407 | 41 | 0.168 | |
| thyroid hormone metabolic process | GO:0042403 | 16 | 0.166 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.166 | |
| cellular response to electrical stimulus | GO:0071257 | 6 | 0.164 | |
| spermatid development | GO:0007286 | 108 | 0.164 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 21 | 0.164 | |
| platelet activation | GO:0030168 | 40 | 0.164 | |
| proprioception | GO:0019230 | 4 | 0.161 | |
| dipeptide transmembrane transport | GO:0035442 | 2 | 0.161 | |
| immunoglobulin secretion involved in immune response | GO:0002380 | 2 | 0.159 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.158 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.158 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.155 | |
| regulation of cell fate specification | GO:0042659 | 10 | 0.153 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.152 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.151 | |
| regulation of excretion | GO:0044062 | 5 | 0.149 | |
| renal system process | GO:0003014 | 48 | 0.148 | |
| establishment of epithelial cell polarity | GO:0090162 | 10 | 0.146 | |
| renal tubule development | GO:0061326 | 87 | 0.145 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.144 | |
| fluid transport | GO:0042044 | 14 | 0.143 | |
| wound healing | GO:0042060 | 157 | 0.140 | |
| cilium assembly | GO:0042384 | 81 | 0.139 | |
| developmental maturation | GO:0021700 | 193 | 0.137 | |
| circulatory system process | GO:0003013 | 197 | 0.137 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.133 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.132 | |
| positive regulation of digestive system process | GO:0060456 | 2 | 0.131 | |
| oxalate transport | GO:0019532 | 3 | 0.128 | |
| nephron tubule development | GO:0072080 | 84 | 0.127 | |
| mesoderm development | GO:0007498 | 100 | 0.126 | |
| neuronal action potential | GO:0019228 | 54 | 0.125 | |
| establishment of epithelial cell apical basal polarity | GO:0045198 | 5 | 0.124 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.124 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.123 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.122 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.122 | |
| atp catabolic process | GO:0006200 | 55 | 0.121 | |
| response to fructose | GO:0009750 | 2 | 0.120 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.119 | |
| regulation of ossification | GO:0030278 | 112 | 0.119 | |
| cell fate determination | GO:0001709 | 32 | 0.118 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.117 | |
| detection of chemical stimulus involved in sensory perception of smell | GO:0050911 | 4 | 0.117 | |
| regulation of platelet activation | GO:0010543 | 17 | 0.116 | |
| respiratory system process | GO:0003016 | 25 | 0.115 | |
| muscle adaptation | GO:0043500 | 39 | 0.115 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.115 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.115 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.115 | |
| detection of visible light | GO:0009584 | 14 | 0.111 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.111 | |
| regulation of protein localization | GO:0032880 | 231 | 0.111 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.109 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.109 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.109 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.109 | |
| regulation of heart growth | GO:0060420 | 31 | 0.108 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.107 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.107 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.107 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.107 | |
| regulation of atrial cardiac muscle cell membrane repolarization | GO:0060372 | 1 | 0.106 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.105 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.104 | |
| dipeptide transport | GO:0042938 | 2 | 0.103 | |
| juxtaglomerular apparatus development | GO:0072051 | 1 | 0.101 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.101 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.101 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.099 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.097 | |
| cation transport | GO:0006812 | 399 | 0.097 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.097 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.095 | |
| cardiac muscle hypertrophy | GO:0003300 | 23 | 0.094 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.094 | |
| retinal cone cell development | GO:0046549 | 8 | 0.094 | |
| regulation of resting membrane potential | GO:0060075 | 3 | 0.092 | |
| response to purine containing compound | GO:0014074 | 28 | 0.091 | |
| microtubule based movement | GO:0007018 | 84 | 0.091 | |
| genetic imprinting | GO:0071514 | 27 | 0.090 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.090 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.089 | |
| positive regulation of wound healing | GO:0090303 | 17 | 0.088 | |
| response to organophosphorus | GO:0046683 | 22 | 0.087 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.087 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.085 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.085 | |
| organ growth | GO:0035265 | 117 | 0.084 | |
| detection of light stimulus involved in visual perception | GO:0050908 | 8 | 0.082 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.081 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.081 | |
| ascending thin limb development | GO:0072021 | 2 | 0.081 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.080 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.079 | |
| female courtship behavior | GO:0008050 | 3 | 0.079 | |
| growth involved in heart morphogenesis | GO:0003241 | 4 | 0.079 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.079 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.079 | |
| nephron epithelium development | GO:0072009 | 92 | 0.079 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.079 | |
| myosin filament assembly | GO:0031034 | 2 | 0.077 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.077 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.077 | |
| cerebellar granule cell differentiation | GO:0021707 | 9 | 0.077 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.076 | |
| establishment of body hair planar orientation | GO:0048105 | 2 | 0.076 | |
| epithalamus development | GO:0021538 | 2 | 0.075 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.075 | |
| establishment of endothelial barrier | GO:0061028 | 5 | 0.075 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.075 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.074 | |
| organelle fission | GO:0048285 | 170 | 0.074 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.074 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.073 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 7 | 0.072 | |
| establishment of monopolar cell polarity | GO:0061162 | 8 | 0.072 | |
| regulation of dipeptide transport | GO:0090089 | 2 | 0.072 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.071 | |
| biomineral tissue development | GO:0031214 | 64 | 0.071 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.071 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.071 | |
| cell cell adhesion mediated by cadherin | GO:0044331 | 5 | 0.071 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.070 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.070 | |
| gastric acid secretion | GO:0001696 | 6 | 0.070 | |
| reproductive behavior | GO:0019098 | 32 | 0.070 | |
| anion transport | GO:0006820 | 177 | 0.070 | |
| germ cell development | GO:0007281 | 185 | 0.070 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.070 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.069 | |
| negative regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902257 | 2 | 0.068 | |
| negative regulation of cytosolic calcium ion concentration | GO:0051481 | 2 | 0.068 | |
| cellular pigmentation | GO:0033059 | 20 | 0.068 | |
| spermatogenesis | GO:0007283 | 284 | 0.068 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.068 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.068 | |
| interleukin 1 production | GO:0032612 | 31 | 0.067 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 12 | 0.067 | |
| spermatid differentiation | GO:0048515 | 115 | 0.067 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.067 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.066 | |
| mitral valve development | GO:0003174 | 4 | 0.066 | |
| intracellular distribution of mitochondria | GO:0048312 | 1 | 0.065 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.064 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.064 | |
| organic acid transport | GO:0015849 | 101 | 0.064 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.064 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.064 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.063 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.062 | |
| renal filtration cell differentiation | GO:0061318 | 10 | 0.062 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.061 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.061 | |
| establishment or maintenance of epithelial cell apical basal polarity | GO:0045197 | 14 | 0.060 | |
| activation of mapk activity | GO:0000187 | 59 | 0.060 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.060 | |
| synaptic transmission | GO:0007268 | 329 | 0.058 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.058 | |
| filopodium assembly | GO:0046847 | 19 | 0.058 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.058 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.057 | |
| regulation of mononuclear cell migration | GO:0071675 | 6 | 0.057 | |
| translational initiation | GO:0006413 | 24 | 0.057 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.057 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.057 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.056 | |
| intracellular protein transport | GO:0006886 | 204 | 0.056 | |
| establishment of pigment granule localization | GO:0051905 | 12 | 0.056 | |
| regulation of epithelial cell differentiation involved in kidney development | GO:2000696 | 10 | 0.056 | |
| pattern specification involved in metanephros development | GO:0072268 | 4 | 0.055 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.054 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.053 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.053 | |
| fertilization | GO:0009566 | 127 | 0.053 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.051 | |
| positive regulation of epidermal cell differentiation | GO:0045606 | 6 | 0.051 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.051 | |
| sodium ion transport | GO:0006814 | 73 | 0.051 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.050 | |
| regulation of gastric acid secretion | GO:0060453 | 2 | 0.050 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.050 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.049 | |
| negative regulation of type b pancreatic cell apoptotic process | GO:2000675 | 3 | 0.049 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.049 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.049 | |
| regulation of dipeptide transmembrane transport | GO:2001148 | 2 | 0.049 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.049 | |
| regulation of ph | GO:0006885 | 26 | 0.048 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.048 | |
| lymphocyte migration | GO:0072676 | 26 | 0.048 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.048 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.048 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.047 | |
| thick ascending limb development | GO:0072023 | 2 | 0.047 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.047 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.047 | |
| regulation of system process | GO:0044057 | 200 | 0.047 | |
| negative regulation of dna binding | GO:0043392 | 20 | 0.045 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.045 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.045 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.044 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.044 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.044 | |
| ossification | GO:0001503 | 216 | 0.044 | |
| oocyte construction | GO:0007308 | 2 | 0.044 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.044 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.043 | |
| positive regulation of exit from mitosis | GO:0031536 | 1 | 0.043 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.043 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.043 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.043 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.043 | |
| regulation of cell motility | GO:2000145 | 236 | 0.042 | |
| renal sodium excretion | GO:0035812 | 3 | 0.042 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.042 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.041 | |
| detection of light stimulus involved in sensory perception | GO:0050962 | 8 | 0.041 | |
| sphingolipid mediated signaling pathway | GO:0090520 | 5 | 0.041 | |
| blastocyst formation | GO:0001825 | 33 | 0.041 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.040 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.040 | |
| detection of glucose | GO:0051594 | 1 | 0.040 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.040 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.040 | |
| cell cell recognition | GO:0009988 | 44 | 0.040 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.040 | |
| rna processing | GO:0006396 | 105 | 0.039 | |
| habenula development | GO:0021986 | 2 | 0.039 | |
| tendon formation | GO:0035992 | 4 | 0.039 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.039 | |
| regulation of platelet derived growth factor receptor signaling pathway | GO:0010640 | 9 | 0.039 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.038 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.038 | |
| lipid homeostasis | GO:0055088 | 63 | 0.038 | |
| renal system development | GO:0072001 | 225 | 0.038 | |
| pigmentation | GO:0043473 | 71 | 0.038 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.038 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.038 | |
| nuclear division | GO:0000280 | 158 | 0.038 | |
| atrial cardiac muscle cell to av node cell signaling | GO:0086026 | 2 | 0.037 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.037 | |
| chloride transport | GO:0006821 | 32 | 0.037 | |
| metanephric juxtaglomerular apparatus development | GO:0072206 | 1 | 0.037 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.037 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.037 | |
| glomerular filtration | GO:0003094 | 7 | 0.037 | |
| cell recognition | GO:0008037 | 83 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.036 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.036 | |
| regulation of filopodium assembly | GO:0051489 | 13 | 0.035 | |
| cerebellum development | GO:0021549 | 77 | 0.035 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.035 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.035 | |
| mononuclear cell migration | GO:0071674 | 8 | 0.035 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.035 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.034 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.034 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.034 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.034 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.034 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.034 | |
| cognition | GO:0050890 | 149 | 0.034 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.033 | |
| respiratory tube development | GO:0030323 | 167 | 0.033 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.033 | |
| cell division | GO:0051301 | 120 | 0.033 | |
| stem cell maintenance | GO:0019827 | 130 | 0.033 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.033 | |
| positive regulation of inositol trisphosphate biosynthetic process | GO:0032962 | 2 | 0.033 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.033 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.033 | |
| hippo signaling | GO:0035329 | 11 | 0.033 | |
| hydrogen transport | GO:0006818 | 35 | 0.033 | |
| peripheral nervous system neuron development | GO:0048935 | 9 | 0.032 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.032 | |
| brain segmentation | GO:0035284 | 3 | 0.032 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.032 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.031 | |
| platelet morphogenesis | GO:0036344 | 13 | 0.031 | |
| deltoid tuberosity development | GO:0035993 | 3 | 0.031 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.031 | |
| embryonic placenta development | GO:0001892 | 98 | 0.031 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.031 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.030 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.030 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.030 | |
| ventricular compact myocardium morphogenesis | GO:0003223 | 2 | 0.030 | |
| long term memory | GO:0007616 | 15 | 0.030 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.030 | |
| regulation of coagulation | GO:0050818 | 31 | 0.030 | |
| atp metabolic process | GO:0046034 | 75 | 0.030 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.030 | |
| chromosome separation | GO:0051304 | 14 | 0.030 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.030 | |
| cerebellar purkinje cell layer development | GO:0021680 | 26 | 0.029 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.029 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.029 | |
| cartilage development | GO:0051216 | 140 | 0.029 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.029 | |
| regulation of macrophage chemotaxis | GO:0010758 | 8 | 0.028 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.028 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.028 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.028 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.028 | |
| organic anion transport | GO:0015711 | 137 | 0.028 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.028 | |
